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Background
HCC is the most common complication of liver cirrho-
sis, and the incidence of HCC increases with age in cir-
rhotic patients. The treatment of HCC in elderly
subjects allows for some considerations. Hepatic resec-
tion can be safely done in cirrhotic HCC patients aging
> 70 years, but the prognosis of these patients is less
favorable than < 70 years patie n t s ,e v e nw h e nc u r a t i v e
resection is achieved.
Liver transplantation is an exceptional measure for
elderly patients, because they have a high incidence of
concurrent diseases and are usually considered a high-
risk group for major surgery. Radiofrequency ablation,
alcohol injection and transcatheter arterial chemoembo-
lization are not surgical treatments for HCC that are
currently performed in elderly patients.
Materials and methods
Because few studies have addressed the outcome of RFA
in elderly patients with HCC, we performed a retrospec-
tive study of 43 elderly patients (age 60-70 years) suffer-
ing from a total of 53 HCC treated with percutaneous
RFA, from January 2002 to January 2008, in the Depart-
ment of Gerontology, Geriatrics and Metabolic Diseases,
Second University of Naples . The indications for RFA
treatment were: HCC consisting of three or fewer
nodules, each nodule having a maximum diameter of 30
mm; HCC consisting of a single tumor, regardless of
size. In all the patients hepatic function was not Child–
Pugh grade C. Survival rates, curative effects, and com-
plications of RFA treatment were evaluated. All of the
53 nodules were percutaneously treated under US gui-
dance with all the patients having conscious sedation or
general anaesthesia. Complete ablation of the lesion
after RFA treatment was assessed in all the patients
using Contrast-enhanced ultrasonography, dynamic CT
scans or MRI every 3–4m o n t h sd u r i n gt h ef o l l o w - u p
period (mean 60 months).
Results
In thirty-five patients (81%) we obtained complete abla-
tion in one session, in six patients (14%) in two sessions
and in two patients (5%) in three sessions. Cumulative
overall survival rates estimated at 3 and 5 years were
79% and 67%, respectively. Cumulative disease-free sur-
vival rates estimated at 3 and 5 years were 31% and
21%, respectively. No major complication occurred.
Conclusions
These results suggest that RFA treatment should be
addressed proactively even if the elderly HCC patient
has concurred diseases. Because the complications from
the RFA procedure were fewer, RFA is considered a reli-
able treatment for HCC in terms of therapeutic efficacy
and safety. RFA treatment might be considered above
hepatic resection for elderly patients.
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